mrna/protamin
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT02452307)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mrna/protamin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00204607 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2004 | University of Tuebingen |
| NCT02452307 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2004 | University of Tuebingen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Tuebingen | Academic/Hospital | 2 | 2 | 1 | 2004 |
1 organizations
Page 1 / 1